As proof of principle, two CTCs from a metastatic breast cancer patient with primary metastatic disease, ER-positive and HER2-negative, were isolated from 10 ml of blood obtained in an EDTA tube. This evidence concerns the gene ERBB2 and metastatic neoplasm.